Original Research
Published on 13 Jul 2021
NU9056, a KAT 5 Inhibitor, Treatment Alleviates Brain Dysfunction by Inhibiting NLRP3 Inflammasome Activation, Affecting Gut Microbiota, and Derived Metabolites in LPS-Treated Mice
in Nutrition and Microbes
Frontiers in Nutrition
doi 10.3389/fnut.2021.701760
- 10,666 views
- 32 citations
